Subscribe to MDT Magazine News

Cardiorobotics collects $6.5M in new funding

February 28, 2011 5:38 am | by Mass High Tech: The Journal of New England Technology | Comments

Raynham-based Cardiorobotics Inc. has raised $6.5 million of a planned $12.5 million funding round, composed of equity and options-based securities, according to federal documents.

AACR to Host U.S. Surgeon General at Congressional Briefing on America's Continuing Tobacco Problem

February 28, 2011 5:35 am | by AACR | Comments

WASHINGTON, D.C. - U.S. Surgeon General Regina M. Benjamin, M.D., M.B.A., will discuss the dangers of tobacco use and her office's recently released report on smoking at an American Association for Cancer Research-sponsored congressional briefing on Tuesday, March 1, 2011.


Allon Therapeutics to Present Live, Online at on March 3rd

February 28, 2011 4:35 am | by Bio-Medicine.Org | Comments

VANCOUVER, British Columbia, Feb. 28, 2011 /- Allon Therapeutics Inc. (TSX: NPC), today announced that Gordon C. McCauley, President and CEO, will present at March 3rd, 2011TIME: 3:00 PM ESTLINK: This will be a live,...


WaferGen Appoints Industry Leader Dr. Timothy J. Triche to Board of Directors

February 28, 2011 4:33 am | by Bio-Medicine.Org | Comments

FREMONT, Calif., Feb. 28, 2011 /- WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS ), a leading developer of state-of-the-art genomic analysis systems, today announced that industry leader Dr. Timothy J. Triche, Professor of Pathology and Pediatrics at the University of Southern...


Heska to Present Live, Online at

February 28, 2011 4:33 am | by Bio-Medicine.Org | Comments

LOVELAND, Colo., Feb. 28, 2011 /- Heska Corporation (Nasdaq: HSKA ; "Heska" or the "Company") today announced it will present at on Thursday, March 3rd, 2011.  The company's presentation is scheduled to begin at 11:00 a.m. Eastern Time (9:00 a.m....


PDL BioPharma settles legal dispute with Novartis

February 28, 2011 3:45 am | by The Associated Press | Comments

Drug developer PDL BioPharma Inc. said Monday it has agreed to settle a legal dispute with Novartis under which it will pay the Swiss drugmaker an amount based on the net sales of the eye drug Lucentis made by Novartis this year and beyond.The settlement resolves all disputes between the...

Varian Medical Systems Announces New $280 Million Accelerated Stock Repurchase

February 28, 2011 3:37 am | by Bio-Medicine.Org | Comments

PALO ALTO, Calif., Feb. 28, 2011 /- Varian Medical Systems, Inc. (NYSE: VAR ) today announced that it has entered into a new agreement with Bank of America N.A. to repurchase $280 million of its common stock under an accelerated share repurchase program.   Under the accelerated...


SinoFresh Healthcare, Inc. Takes Groundbreaking Products to Europe

February 28, 2011 3:36 am | by Bio-Medicine.Org | Comments

VENICE, Fla., Feb. 28, 2011 /- SinoFresh® HealthCare, Inc., (Pink Sheets: SFSH ) announced today that its Senior Management Team has initiated a program to launch SinoFresh products in international markets. This would more than double the potential size of the market in the United...


Omni Bio Pharmaceutical Intends to Expand Type 1 Diabetes Trial to 50 Patients

February 28, 2011 3:35 am | by Bio-Medicine.Org | Comments

DENVER, Feb. 28, 2011 /- (OTC Bulletin Board: OMBP ) Omni Bio Pharmaceutical, Inc. ("Omni Bio"), an emerging biopharmaceutical company formed to acquire, license, and develop existing therapies for indications with substantial commercialization potential, has committed to expand its Phase...


Intuity Medical Secures $20M Credit Facility From Silicon Valley Bank and Oxford Finance Corporation

February 28, 2011 3:35 am | by Bio-Medicine.Org | Comments

SUNNYVALE, Calif., Feb. 28, 2011 /PRNewswire/ -- Intuity Medical, Inc .™, a privately-held company developing innovative technologies in diabetes management, announced that it has secured a $20M credit facility from Silicon Valley Bank and Oxford Finance Corporation . The funds will...


OncoGenex Pharmaceuticals to Participate in Panel Discussion on Novel Cancer Treatments at RBC Capital Markets Healthcare Conference

February 28, 2011 3:34 am | by Bio-Medicine.Org | Comments

BOTHELL, Wash., and VANCOUVER, British Columbia, Feb. 28, 2011 /- OncoGenex Pharmaceuticals, Inc. (Nasdaq: OGXI ) announced today that Scott Cormack, OncoGenex's president and chief executive officer, will take part in a panel discussion on novel cancer treatments at the upcoming RBC...


ACD Announces Clinical Study Results Using its RNAscopeâ„¢ Technology

February 28, 2011 3:33 am | by Bio-Medicine.Org | Comments

SAN ANTONIO, Feb. 28, 2011 /- Advanced Cell Diagnostics, Inc. (ACD) today announced the results of its clinical study utilizing RNAscope™ technology to detect human papillomavirus (HPV) E6/E7 mRNA in routine clinical specimens of head and neck cancer. HPV status determined by the...


Negative Pressure Wound Therapy (NPWT) systems - Preliminary Public Health Notification

February 28, 2011 3:30 am | by U.S. Food & Drug Administration | Comments

UPDATED 02/28/2011. Reports of deaths and serious complications, especially bleeding and infection, associated with NPWT.


Hotspur's Keeper Embolectomy Catheter Deployed for First Time

February 28, 2011 2:35 am | by Bio-Medicine.Org | Comments

MOUNTAIN VIEW, Calif., Feb. 28, 2011 /- Hotspur Technologies announced today that Dr. Thomas DiBartholomeo of Fairfield, CT, performed the first clinical use of its Keeper™ Embolectomy Catheter.  The Keeper Catheter enables physicians to clear clot formation within arteries,...


Greater diagnostic accuracy in pulse-wave velocity measurement

February 28, 2011 1:34 am | by RealWire | Comments

24-hour device developed by AIT in cooperation with I.E.M.The Austrian research institute AIT Austrian Institute of Technology has in cooperation with German industrial partner I.E.M. developed a 24-hour device to measure blood pressure that basically provides a more-exact diagnosis of...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.